disease progression

Research Reports

Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs

11/27/2017

Ladan Golestaneh, MD, MS

Paula J Alvarez, RPh, MPH, MBA

Nancy L Reaven, MA

Susan E Funk, MBA, FACHE

Karen J McGaughey, PhD

Alain Romero, PharmD, PhD

Macaulay Onuigbo, MD, MSc, MBA

Editor's Note: This article was updated for minor editorial additions and formatting changes, per request of the authors. Abstract: In order to identify drivers of chronic kidney disease (CKD) stage progression and...

...

11/27/2017

Journal of Clinical Pathways

Research in Review

Effectiveness of Drug for First-Line Treatment of EGFR+ Non-Small Cell Lung Cancer Supported by New Study

01/08/2016

JCP Editors

First-line treatment with erlotinib for epidermal growth factor receptor (EGFR) mutation–positive non-small cell lung cancer (NSCLC) patients may have benefits even after disease progresses, a new study...

...

01/08/2016

Journal of Clinical Pathways